Member Board of Directors @ (August 2025 - Present)
Strategic Advisor @ (November 2023 - Present)
Strategic Advisor @ (June 2024 - March 2026)
Member Board of Directors @ (May 2025 - November 2025)
Member Board of Directors @ (August 2024 - May 2025)
Interim President and Chief Executive Officer @ (August 2024 - March 2025)
President and Chief Executive Officer @ CTI BioPharma Corp. (March 2017 - June 2023)
President @ Medarc Consulting LLC (December 2015 - March 2017)
Interim Chief Medical Officer @ Immune Design (June 2016 - October 2016)
EVP, Development and Chief Medical Officer @ (February 2012 - December 2015)
Chief Medical Officer, Senior Vice President @ ChemGenex Pharmaceuticals, Inc. (a wholly owned subsidiary of Teva Pharmaceutica (September 2007 - December 2011)
Adam Craig Education
Charing Cross and Westminster Medical School, University of London
MB BS (BSc (Hons.))
Molecular Medicine Unit, University of Leeds
PhD (Molecular Pathology of Acute Leukemia)
Adam Craig Skills
Life Sciences
Oncology
Clinical Development
Drug Development
Pharmaceutical Industry
Infectious Diseases
Lifesciences
Clinical Trials
Biopharmaceuticals
Biotechnology
Drug Discovery
CRO
Commercialization
Regulatory Affairs
Management
Clinical Research
Business Development
Healthcare
Customer Service
Process Improvement
Sales
Adam Craig Summary
Adam Craig, based in United Kingdom, is currently a Strategic Advisor, Hematology at Syntara. Adam Craig brings experience from previous roles at X4 Pharmaceuticals, eGenesis, Inc., DRI Healthcare and Northpond Ventures. Adam Craig holds a MB BS in BSc (Hons.) @ Charing Cross and Westminster Medical School, University of London. With a robust skill set that includes Life Sciences, Oncology, Clinical Development, Drug Development, Pharmaceutical Industry and more. Adam Craig has 5 emails and 6 mobile phone numbers on RocketReach.
Looking for a different Adam Craig?
Find contact details for 700 million professionals.